October 2020

Craig-Hallum and The Benchmark Company Underwrite $19M Public Offering for Processa Pharmaceuticals

Craig-Hallum Capital Group and The Benchmark Company acted as underwriters in a $19 million public offering and uplisting for Processa Pharmaceuticals, Inc. Faegre Drinker represented the underwriters in the transaction.

Pursuant to the offering, Processa issued 4.8 million shares of common stock at a public offering price of $4.00 per share. 

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.